Home/Filings/4/0001209191-23-049102
4//SEC Filing

Lettmann Jason 4

Accession 0001209191-23-049102

CIK 0001810182other

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 4:24 PM ET

Size

5.4 KB

Accession

0001209191-23-049102

Insider Transaction Report

Form 4
Period: 2023-09-08
Lettmann Jason
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-09-08+1,200,0001,200,000 total
    Exercise: $4.92Exp: 2033-09-07Common Stock (1,200,000 underlying)
Footnotes (1)
  • [F1]One-fourth of the shares subject to the option vest on September 5, 2024 and 1/48th of the shares vest monthly thereafter.

Issuer

ALX ONCOLOGY HOLDINGS INC

CIK 0001810182

Entity typeother

Related Parties

1
  • filerCIK 0001688269

Filing Metadata

Form type
4
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 4:24 PM ET
Size
5.4 KB